Enjoy complimentary customisation on priority with our Enterprise License!
Drug device combination products consist of two regulated components, an active pharmaceutical ingredient and a medical device, which are chemically of physically combined to develop a single component. The global drug device combination products market is expected to exhibit rapid growth during the forecast period and is positively affected by factors like its high revenue generating capacity across the healthcare sector and its ability to optimize product life cycles. These factors augment the prospects for growth in this market during the forecast period and results in its impressive CAGR of more than 11% by 2019.
The increase in patient population for chronic diseases is the key driver for the growth of this market. The prevalence of chronic diseases like cardiovascular disease, diabetes, and respiratory diseases is estimated to increase rapidly during the forecast period. This increase in the prevalence of chronic diseases is estimated to bolster the demand for smooth and efficient drug delivery devices, which in turn would augment the prospects for growth in this market during the forecast period.
In this market research report, Technavio analysts estimate the drug-eluting stents segment to account for more than 36% of the total market share by 2019. The rising prevalence of cardiovascular diseases and the recent rise in demand for minimally invasive surgical procedures are the two major factors that promote growth in this segment during the forecast period.
Technavio’s market research analyst has estimated the Americas to be the major revenue contributing geography during the forecast period. Factors like the rising aging population and the introduction of favorable healthcare reforms aid in promoting the prospects for growth in this region during the forecast period.
This market is estimated to offer tremendous growth opportunities to the vendors during the forecast period. Vendors that have the ability to efficiently manufacture and offer a wide variety of drug-device combination products, such as infusion pumps, insulin injections, and drug-eluting stents, are expected to gain a competitive edge over their rivals.
Leading vendors in this market are -
Other prominent vendors analyzed in this market study are Aerogen, Airon, Allied Healthcare Products, AstraZeneca, Boehringer Ingelheim, B. Braun Medical, Briggs Healthcare, BIOTRONIK, Cook Medical, Cardinal Health, Consort Medical, Clement Clarke International, Concordia, C.R. Bard, DeVilbiss Healthcare, Ethicon, GlaxoSmithKline, Gerresheimer, Heyer Medical, Invacare, Lepu Medical Technology, MicroPort Scientific, Mylan, Medline Industries, Mallinckrodt, Nypro, Omron Healthcare, PARI Medical, Phillips Healthcare, RPC Bramlage, Salter Labs, Smart inhaler, Stryker, Sunovion Pharmaceuticals, Teleflex, Terumo, Vortran Medical, and W. L. Gore & Associates.
Technavio also offers customization on reports based on specific client requirement.
This is preliminary content. The table of contents is subject to change.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product
PART 07: Geographical segmentation
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
PART 15: Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.